Literature DB >> 22492997

DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway.

Joo-Young Im1, Kang-Woo Lee, Jong-Min Woo, Eunsung Junn, M Maral Mouradian.   

Abstract

DJ-1, which is linked to recessively inherited Parkinson's disease when mutated, is a multi-functional protein with anti-oxidant and transcription regulatory activities. However, the mechanism(s) through which DJ-1 and the genes it regulates provide neuroprotection is not fully understood. Here, we show that wild-type DJ-1 induces the expression of thioredoxin 1 (Trx1), a protein disulfide oxidoreductase, whereas pathogenic mutant isoforms L166P and M26I cannot. Conversely, DJ-1 knockdown in SH-SY5Y cells and DJ-1 knockout in mice result in significant decrease in Trx1 protein and mRNA expression levels. The importance of Trx1 in the cytoprotective function of DJ-1 is confirmed using a pharmacological inhibitor of Trx reductase, 1-chloro-2,4-dinitrobenzene, and Trx1 siRNA. Both approaches result in partial loss of DJ-1-mediated protection. Additionally, knockdown of Trx1 significantly abrogates DJ-1-dependent, hydrogen peroxide-induced activation of the pro-survival factor AKT. Promoter analysis of the human Trx1 gene identified an antioxidant response element (ARE) that is required for DJ-1-dependent induction of Trx1 expression. The transcription factor Nuclear factor erythroid-2 related factor 2 (Nrf2), which is a critical inducer of ARE-mediated expression, is regulated by DJ-1. Overexpression of DJ-1 results in increased Nrf2 protein levels, promotes its translocation into the nucleus and enhances its recruitment onto the ARE site in the Trx1 promoter. Further, Nrf2 knockdown abolishes DJ-1-mediated Trx1 induction and cytoprotection against hydrogen peroxide, indicating the critical role of Nrf2 in carrying out the protective functions of DJ-1 against oxidative stress. These findings provide a new mechanism to support the antioxidant function of DJ-1 by increasing Trx1 expression via Nrf2-mediated transcriptional induction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492997      PMCID: PMC3373246          DOI: 10.1093/hmg/dds131

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  54 in total

1.  Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors.

Authors:  Y C Kim; H Masutani; Y Yamaguchi; K Itoh; M Yamamoto; J Yodoi
Journal:  J Biol Chem       Date:  2001-03-01       Impact factor: 5.157

2.  Keap1-Nrf2 activation in the presence and absence of DJ-1.

Authors:  Li Gan; Delinda A Johnson; Jeffrey A Johnson
Journal:  Eur J Neurosci       Date:  2010-03-03       Impact factor: 3.386

3.  Excitotoxic hippocampal injury is attenuated in thioredoxin transgenic mice.

Authors:  Y Takagi; I Hattori; K Nozaki; A Mitsui; M Ishikawa; N Hashimoto; J Yodoi
Journal:  J Cereb Blood Flow Metab       Date:  2000-05       Impact factor: 6.200

4.  Oxidation of DJ-1-dependent cell transformation through direct binding of DJ-1 to PTEN.

Authors:  Yun-Chul Kim; Hirotake Kitaura; Takahiro Taira; Sanae M M Iguchi-Ariga; Hiroyoshi Ariga
Journal:  Int J Oncol       Date:  2009-12       Impact factor: 5.650

5.  Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK.

Authors:  T Nguyen; H C Huang; C B Pickett
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

6.  Multiple coregulatory control of tyrosine hydroxylase gene transcription.

Authors:  Sirigiri Divijendra Natha Reddy; Suresh K Rayala; Kazufumi Ohshiro; Suresh B Pakala; Nobuhide Kobori; Pramod Dash; Sung Yun; Jun Qin; Bert W O'Malley; Rakesh Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-22       Impact factor: 11.205

7.  Geranylgeranylacetone enhances expression of thioredoxin and suppresses ethanol-induced cytotoxicity in cultured hepatocytes.

Authors:  K Hirota; H Nakamura; T Arai; H Ishii; J Bai; T Itoh; K Fukuda; J Yodoi
Journal:  Biochem Biophys Res Commun       Date:  2000-09-07       Impact factor: 3.575

8.  DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway.

Authors:  Hossein Aleyasin; Maxime W C Rousseaux; Paul C Marcogliese; Sarah J Hewitt; Isabella Irrcher; Alvin P Joselin; Mohammad Parsanejad; Raymond H Kim; Patrizia Rizzu; Steve M Callaghan; Ruth S Slack; Tak W Mak; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

9.  Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin.

Authors:  Xiao-Nan Li; Jun Song; Lin Zhang; Scott A LeMaire; Xiaoyang Hou; Cheng Zhang; Joseph S Coselli; Li Chen; Xing Li Wang; Yun Zhang; Ying H Shen
Journal:  Diabetes       Date:  2009-07-10       Impact factor: 9.461

10.  Attenuation of neuronal degeneration in thioredoxin-1 overexpressing mice after mild focal ischemia.

Authors:  Feng Zhou; Masanori Gomi; Motoaki Fujimoto; Makoto Hayase; Takeshi Marumo; Hiroshi Masutani; Junji Yodoi; Nobuo Hashimoto; Kazuhiko Nozaki; Yasushi Takagi
Journal:  Brain Res       Date:  2009-03-25       Impact factor: 3.252

View more
  72 in total

Review 1.  Nuclear Factor (Erythroid-Derived 2)-Like 2 and Thioredoxin-1 in Atherosclerosis and Ischemia/Reperfusion Injury in the Heart.

Authors:  Philipp Jakobs; Vlad Serbulea; Norbert Leitinger; Anna Eckers; Judith Haendeler
Journal:  Antioxid Redox Signal       Date:  2017-01-18       Impact factor: 8.401

2.  Regulation of Signal Transduction by DJ-1.

Authors:  Stephanie E Oh; M Maral Mouradian
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

3.  Regulation of DJ-1 by Glutaredoxin 1 in Vivo: Implications for Parkinson's Disease.

Authors:  William M Johnson; Marcin Golczak; Kyonghwan Choe; Pierce L Curran; Olga Gorelenkova Miller; Chen Yao; Wenzhang Wang; Jiusheng Lin; Nicole M Milkovic; Ajit Ray; Vijayalakshmi Ravindranath; Xiongwei Zhu; Mark A Wilson; Amy L Wilson-Delfosse; Shu G Chen; John J Mieyal
Journal:  Biochemistry       Date:  2016-08-01       Impact factor: 3.162

Review 4.  Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

Authors:  G Morris; A J Walker; K Walder; M Berk; W Marx; A F Carvalho; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

Review 5.  Mitochondrial biology in airway pathogenesis and the role of NRF2.

Authors:  Hye-Youn Cho; Steven R Kleeberger
Journal:  Arch Pharm Res       Date:  2019-09-04       Impact factor: 4.946

6.  Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.

Authors:  Briana R De Miranda; Emily M Rocha; Qing Bai; Amina El Ayadi; David Hinkle; Edward A Burton; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2018-04-09       Impact factor: 5.996

7.  Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1.

Authors:  Santiago Cuevas; Yu Yang; Prasad Konkalmatt; Laureano D Asico; Jun Feranil; John Jones; Van Anthony Villar; Ines Armando; Pedro A Jose
Journal:  Hypertension       Date:  2015-04-20       Impact factor: 10.190

8.  Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity.

Authors:  Nirit Lev; Yael Barhum; Tali Ben-Zur; Eldad Melamed; Israel Steiner; Daniel Offen
Journal:  J Mol Neurosci       Date:  2013-03-28       Impact factor: 3.444

9.  Decreased DJ-1 leads to impaired Nrf2-regulated antioxidant defense and increased UV-A-induced apoptosis in corneal endothelial cells.

Authors:  Cailing Liu; Yuming Chen; Irene E Kochevar; Ula V Jurkunas
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-31       Impact factor: 4.799

10.  KEAP1-NRF2 complex in ischemia-induced hepatocellular damage of mouse liver transplants.

Authors:  Bibo Ke; Xiu-Da Shen; Yu Zhang; Haofeng Ji; Feng Gao; Shi Yue; Naoko Kamo; Yuan Zhai; Masayuki Yamamoto; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  J Hepatol       Date:  2013-07-16       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.